Amundi Index Solutions - Amundi Index Equity Global Multi Smart Allocation Scientific Beta RE-C EURRegister to Unlock Ratings |
Performance History | 30/06/2023 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | 3.0 | 20.3 | -3.8 | -0.1 | |
+/-Cat | - | -11.3 | 5.3 | 6.0 | - | |
+/-B’mrk | - | -9.5 | 1.3 | 4.2 | - | |
Category: Global Flex-Cap Equity | ||||||
Category Benchmark: Morningstar Global All Cap ... |
Key Stats | ||
NAV 29/06/2023 | EUR 124.03 | |
Day Change | 0.31% | |
Morningstar Category™ | Global Flex-Cap Equity | |
ISIN | LU1437019216 | |
Fund Size (Mil) 16/05/2024 | EUR 37.06 | |
Share Class Size (Mil) 29/06/2023 | EUR 0.08 | |
Max Initial Charge | 4.50% | |
Ongoing Charge 11/02/2022 | 0.30% |
Investment Objective: Amundi Index Solutions - Amundi Index Equity Global Multi Smart Allocation Scientific Beta RE-C EUR |
To track the performance of Scientific Beta Developed Multi-Beta Multi-Strategy Four-Factor ERC Index ("the Index"), and to minimize the tracking error between the net asset value of the sub-fund and the performance of the Index. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Nobuaki Kato 05/01/2017 | ||
Inception Date 08/12/2016 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
Scientific Beta Dev MB MS F-F ERC NR EUR | Morningstar Global All Cap TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Amundi Index Solutions - Amundi Index Equity Global Multi Smart Allocation Scientific Beta RE-C EUR | 15/05/2024 |
|
|
Top 5 Holdings | Sector | % |
Merck & Co Inc | Healthcare | 0.89 |
Exxon Mobil Corp | Energy | 0.73 |
Vertex Pharmaceuticals Inc | Healthcare | 0.67 |
Spotify Technology SA | Communication Services | 0.57 |
Regeneron Pharmaceuticals Inc | Healthcare | 0.52 |
Increase Decrease New since last portfolio | ||
Amundi Index Solutions - Amundi Index Equity Global Multi Smart Allocation Scientific Beta RE-C EUR |